Head-To-Head Comparison: Chemours (NYSE:CC) and General Enterprise Ventures (OTCMKTS:GEVI)

General Enterprise Ventures (OTCMKTS:GEVI) and Chemours (NYSE:CC) are both construction companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Analyst Ratings

This is a summary of current ratings for General Enterprise Ventures and Chemours, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
General Enterprise Ventures	0	0	0	0	0.00
Chemours	0	5	3	0	2.38

Chemours has a consensus price target of $24.13, indicating a potential upside of 36.53%. Given Chemours’ stronger consensus rating and higher probable upside, analysts plainly believe Chemours is more favorable than General Enterprise Ventures.

Earnings and Valuation

This table compares General Enterprise Ventures and Chemours”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
General Enterprise Ventures	$520,000.00	60.16	-$10.10 million	($0.08)	-10.63
Chemours	$5.75 billion	0.46	-$238.00 million	$0.50	35.34

General Enterprise Ventures has higher earnings, but lower revenue than Chemours. General Enterprise Ventures is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

General Enterprise Ventures has a beta of 5.33, meaning that its share price is 433% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500.

Profitability

This table compares General Enterprise Ventures and Chemours’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
General Enterprise Ventures	-544.66%	-162.24%	-104.56%
Chemours	1.34%	29.48%	2.74%

Insider & Institutional Ownership

76.3% of Chemours shares are held by institutional investors. 0.5% of Chemours shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Chemours beats General Enterprise Ventures on 11 of the 14 factors compared between the two stocks.

About General Enterprise Ventures

General Enterprise Ventures, Inc., engages in installing large home and facility proactive wildfire prevention systems. It offers CitroTech products for the prevention and spread of wildfires, as well as lumber treatments for fire prevention. The company was formerly known as General Entertainment Ventures, Inc. and changed its name to General Enterprise Ventures, Inc. in October 2021. General Enterprise Ventures, Inc. is based in Cheyenne, Wyoming.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.